Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/44893
Title: Lymphocutaneous Sporotrichosis Refractory to First-Line Treatment
Authors: BELDA, W.PASSERO, L. F. DominguesCASOLATO, A. T. Stradioto
Citation: CASE REPORTS IN DERMATOLOGICAL MEDICINE, v.2021, article ID 9453701, p, 2021
Abstract: Sporotrichosis is a fungal infection endemic in Latin America and has been attributed to the thermodimorphic fungus of the genus Sporothrix. Transmission to humans occurs during a traumatic injury with soil or organic material; additionally, lesions caused by infected cats play an important role in the epidemiology of the disease. The classic treatment of sporotrichosis is performed with itraconazole or potassium iodide; second-line medications, such as amphotericin B and terbinafine, can alternatively be used in cases of first-line drug failure. In the present study, a patient with lymphocutaneous sporotrichosis in the right upper limb exhibited intolerance to itraconazole and potassium iodide, additionally during the period of use; these drugs did not control skin lesions. In this patient, amphotericin B deoxycholate and its liposomal version were used in this patient; and complete recovery of the lesions was observed. © 2021 Walter Belda et al.
Appears in Collections:

Artigos e Materiais de Revistas Científicas - FM/MDT
Departamento de Dermatologia - FM/MDT

Artigos e Materiais de Revistas Científicas - HC/ICHC
Instituto Central - HC/ICHC

Artigos e Materiais de Revistas Científicas - LIM/50
LIM/50 - Laboratório de Patologia das Moléstias Infecciosas


Files in This Item:
File Description SizeFormat 
art_BELDA_Lymphocutaneous_Sporotrichosis_Refractory_to_FirstLine_Treatment_2021.PDFpublishedVersion (English)2.77 MBAdobe PDFThumbnail
View/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.